Towards commercialization of bias-switchable row-column ultrasound arrays

实现偏置可切换行列超声阵列的商业化

• 批准号: 536752-2019
• 负责人: Zemp, Roger
• 金额: $ 9.11万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Idea to Innovation
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-01-01 至 2020-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=693392
• 关键词: Towards; commercialization; bias; switchable; row

We are aiming to commercialize a novel bias-switchable row-column 2D ultrasound transducer technology with first application to high-resolution 3D imaging in pre-clinical markets. For high-frequencies, such arrays do not exist due to fabrication challenges and readout difficulties. However, there is significant demand for such arrays for both pre-clinical and clinical markets. We first aim to develop 10-20MHz prototypes for commercialization in pre-clinical markets. If aims of this grant are successful, we will aim to spin-off a company which would partner with two key companies, FUJIFILM Visualsonics and Verasonics for selling such array sub-systems along with imaging platforms sold by these partners. They have provided support letters. Success in pre-clinical arenas would then position the potential spin-off for launching into larger clinical markets.

我们的目标是将一种新型的偏置可切换行列2D超声换能器技术商业化，并首次应用于临床前市场的高分辨率3D成像。对于高频，由于制造挑战和读出困难，这样的阵列不存在。然而，对于临床前和临床市场两者，存在对这样的阵列的显著需求。我们的首要目标是开发10- 20 MHz原型，用于临床前市场的商业化。如果这笔赠款的目标是成功的，我们将致力于分拆一家公司，该公司将与两家主要公司，富士视觉和Verasonics合作，沿着这些合作伙伴销售的成像平台销售此类阵列子系统。他们提供了支持信。在临床前领域的成功将使潜在的分拆产品进入更大的临床市场。